RTKN2 is Associated with Unfavorable Prognosis and Promotes Progression in Non-Small-Cell Lung Cancer

Background: Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. However, the molecular mechanism of NSCLC remains unknown. Accumulating data show that Rhotekin 2 (RTKN2) functions as a novel crucial regulator of diverse biological processes; however, its pa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	OncoTargets and therapy 2020-01, Vol.13, p.10729-10738
Hauptverfasser:	Li, Lupeng, Huang, Yucun, Zhang, Yi, Peng, Anping, Qin, Jilong, Lu, Shaofan, Huang, Yu
Format:	Artikel
Sprache:	eng
Schlagworte:	Apoptosis Bcl-2 protein Biotechnology & Applied Microbiology Cell adhesion & migration Cell migration Cell proliferation Gelatinase A Gelatinase B Gene expression Hospitals Life Sciences & Biomedicine Lung cancer Matrix metalloproteinase Medical prognosis Metalloproteinase Metastasis Mortality mRNA Non-small cell lung carcinoma Oncology Original Research Patients Proteins Science & Technology Small cell lung carcinoma Statistical analysis Survival analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!